Abstract
ARTERIAL HIPERTENSION AND PULS WAVE VELOCITY
Aim. The purpose of the study is to identify the connection between high blood pressure and PWV in patients with AH and determine if AH is a risk factor that accelerates the development of atherosclerosis.
Material and methods. With quantitative research method we investigated, explained, and defi ned the eff ects of arterial hypertension with the PWV increase‐rate observed across diff erent age groups of patients who already have AH. Data from patients’ medical records from the At Cor Sphygmocor operating system were extracted.
Results. The sample included 191 patients with AH. PWV values were normal in 72% of patients with optimal blood pressure (BP), 60% of patients with normal BP had increased PWV in high normal BP and grade 1 AH were 53% of increased PWV, 53% of normal PWV in grade 2 AH, increased in 94% in grade 3 AH, and 50% of patients had increased PWV values in isolated systolic AH.
Conclusions. The research results undoubtedly show the importance of arterial hypertension for the increase in pulse wave velocity, with the clearest correlation at grade 3 AH and in the age groups between 30 and 49 years. On average, the PWV value in hypertensive patients rose by 8%, which represents an increased risk of cardiovascular complications.
References
1. Božič N, Knez J, Dolenc P, et al. Mesec meritev maj 2019. [in:] Dolenc P, ed. XXVIII. Strokovni sestanek združenja za arterijsko hipertenzijo. Ljubljana: Združenje za arterijsko hipertenzijo. Slovensko zdravniško društvo; 2019, s. 105-108.
2. Accetto R, Salobir B, BrguljanHitij J, et al. Slovenske smernice za obravnavo hipertenzije. Zdravniški vestnik. 2014; 83 (11): 727-758.
3. Dolenc P, Vujanić, A. Definicija arterijske hipertenzije. [in:] Dolenc P ed. XXVII. Strokovni sestanek združenja za arterijsko hipertenzijo. Ljubljana: Združenje za arterijsko hipertenzijo, Slovensko zdravniško društvo; 2018, s. 15-24.
4. Yuhua Z, Xuemei X, Zhenzhen W, et al. Research progress on the relationship between atherosclerosis and inflammation. Biomolecules. 2018; 8(3): 1-11.
5. Ježovnik M, Poredoš P. Vnetje – skupni patogenetski dejavnik arterijske aterosklerotične in venske trombembolične bolezni. Zdravniški vestnik. 2017; 86(5/6): 244-254.
6. Vallée A. Arterial Stiffness Determinants for Primary Cardiovascular Prevention among Healty participants. Journal of Clinical Medicine. 2022; 11(9): 2512: 1-11.
7. Turk M, Lunder M, Janić M, at al. Pomen hitrostipulzneg avala in centralnega arterijskega tlaka v klinični praksi. Medicinski razgledi. 2014; 53(2): 171-180.
8. Laurent S, Chatellier G, Azizi M, et al. SPARTE Study: Normalization of arterial stiffness and cardiovascular events in patients with hypertension at medium to very high risk. Hypertension. 2021; 78(4): 983-995.
9. Čegovnik B, Salobir B, Salobir N. Interpretacija izvidov za oceno s hipertenzijo povzročene prizadetosti organov. [in:] Dolenc P, ed. XXVIII. Strokovni sestanek združenja za arterijsko hipertenzijo. Ljubljana: Združenje za arterijsko hipertenzijo. Slovensko zdravniško društvo; 2019, s. 23-32.
10. Brunner-La Rocca HP. Towards applicability of measures of arterial stiffness in clinical routine. European heart journal. 2010; 31(19): 2320-2322.
11. Brguljan Hitij J, Dolenc P, Erhartič A, et al. Slovenske smernice za obravnavo hipertenzije, 2018, skrajšana verzija. [in:] Brguljan Hitij J, Dolenc P, Erhartič A, ed. Ljubljana: Združenje za arterijsko hipertenzijo. Slovensko zdravniško društvo; 2019.
12. Reisp M, Laznik G. Vpliv arterijske hipertenzije na poras thitrosti pulznega vala. [in:] Berkopec M ed. Izzivi integrirane zdravstvene in socialne oskrbe v času epidemije: Novo mesto. Društvo medicinskih sester, babic in zdravstvenih tehnikov Splošna bolnišnica Novo mesto Univerza v Novem mestu, Fakulteta za zdravstvene vede; 2022, s. 14-15.
13. Balder JW, Rimbert A, Zhang X, et al. Genetics, Lifestyle, and low-Density Lipoprotein Cholesterol in Young and Apparently Healthy Women. Circulation. 2018; 137(8): 820-831.
14. Ishiyama Y, Hoshide S, Kanegae H, et al. Impact of home blood pressure variability on cardiovascular outcome in patients with arterial stiffness: Results of the J-HOP study. The journal of clinical hypertension. 2021; 23(8): 1529-1537.
15. Božič N, Brguljan Hitij J. Register bolnikov z malign hipertenzijo. [in:] Dolenc P, ed. XXV. Strokovni sestanek združenja za arterijsko hipertenzijo. Ljubljana: Združenje za arterijsko hipertenzijo.Slovensko zdravniško društvo; 2016, s. 33-37.
16. Cevc M. Hipertenzija in hiperlipidemija. [in:] Dolenc P, ed. XXV. Strokovn isestanek Združenja za arterijsko hipertenzijo. Združenje za arterijsko hipertenzijo. Slovensko zdravniško društvo; 2016, s. 63-72.
17. Boutouyre P, Chowienczyk P, Humphrey JD, et al. arterial stiffness and cardiovascular risk in hypertension. Circulation research. 2021; 128(7): 864-886.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Authors